The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smolentseva I.G.

Russian Medical Academy of Continuous Professional Education;
Central Clinical Hospital with Polyclinic of Medical Center the Administrative

Kuzmina A.V.

Russian Medical Academy of Continuing Professional Education

Levin O.S.

Russian Medical Academy of Continuous Professional Education

Clinical and kinematic analysis of swimming disorders in Parkinson’s disease

Authors:

Smolentseva I.G., Kuzmina A.V., Levin O.S.

More about the authors

Read: 422 times


To cite this article:

Smolentseva IG, Kuzmina AV, Levin OS. Clinical and kinematic analysis of swimming disorders in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(12):120‑125. (In Russ.)
https://doi.org/10.17116/jnevro2025125121120

Recommended articles:
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14
Arti­ficial inte­lligence in comprehensive reha­bilitation of people with disa­bilities. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(3):54-61

References:

  1. Levin OS. Algoritmy diagnostiki i lecheniya bolezni Parkinsona. M.: Meditsinskoe informatsionnoe agentstvo. 2018. (In Russ.).
  2. Opara J, Malecki A, Malecka E, et al. Motor assessment in Parkinson`s disease. Ann Agric Environ Med. 2017;24(3):411-415.  https://doi.org/10.5604/12321966.1232774
  3. Bolezn’ Parkinsona i rasstroistva dvizhenii. Pod red. Illarioshkina S.N., Levina O.S. M.: ZAO «RKI Sovero press». 2014. (In Russ.).
  4. Postuma RB, Berg D, Stern M, et al. MDS Clinical Diagnostic Criteria for Parkinson’s Disease. Movement Disorders. 2015;30(12):1591-1599. https://doi.org/10.1002/mds.26424
  5. Levin OS, Artem’ev DV, Bril’ EV, et al. Bolezn’ Parkinsona: sovremennye podkhody k diagnostike i lecheniyu. Prakticheskaja medicina. 2017;1(102):45-51. (In Russ.).
  6. Levin OS, Fedorova NV. Bolezn’ Parkinsona. 7-e izd. M.: MEDpress-inform. 2017;384. (In Russ.).
  7. Illarioshkin SN. Modern view on etiology of Parkinson’s disease. Nevrologicheskiy zhurnal. 2015;20(4):4-13. (In Russ.).
  8. Levin OS, Datieva VK. Tremors in Parkinson’s disease: features of phenomenology and treatment. STPN. 2014;3:14-19. (In Russ.).
  9. Krivonos OV, Smolentseva IG, Amosova NA. Epidemiological monitoring the of Parkinson’s disease morbidity. Saratovskij nauchno-medicinskij zhurnal. 2013;4:12-18. (In Russ.).
  10. Katunina EA, Zalyalova ZA, Pokhabov DV, et al. Parkinson’s disease. Focus on early stages. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2023;15(3):95-103. (In Russ.). https://doi.org/10.14412/2074-2711-2023-3-95-103
  11. Nodel MR. The impact of neuropsychiatric symptoms on quality of life of patients with Parkinson’s disease. Nevrologicheskii zhurnal. 2015;20(1):20-27. (In Russ.). https://doi.org/10.18821/1560-9545-2015-20-1-20-27
  12. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017;18(7):435-450.  https://doi.org/10.1038/nrn.2017.62
  13. Nodel MR, Makhmudova GZh, Niinoja IV, et al. Impact of affective and cognitive impairments on quality of life in patients. Rossijskij nevrologicheskij zhurnal. 2022;27(4):62-68. (In Russ.). https://doi.org/10.30629/2658-7947-2022-27-4-62-68
  14. Katunina EA, Bezdol’nyi YuN, Malykhina EA., et al. Opyt primeneniya levodopy-benserazida. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2015;3:93-97. (In Russ.).
  15. Fedorova NV, Omarova SM. Levodopa-Induced Dyskinesias in Parkinson’s Disease: Pharmacotherapy and Neurosurgical Treatment. Nervnye bolezni. 2017;1:22-28. (In Russ.).
  16. Ragimova AA, Samushiya MA, Ivolgin AF, et al. Neuropsychiatric symptoms of Parkinson’s disease in the non-motor stage. Kremlevskaya meditsina. Klinicheskii vestnik. 2019;4:45-56. (In Russ.). https://doi.org/10.26269/qbn4-g055
  17. Rajput AH, Fenton ME, Birdi S, et al. Clinical-pathological study of levodopa complications. Mov Dis. 2002;17:289-296.  https://doi.org/10.1002/mds.10031
  18. Blanchet PJ. The fluctuating parkinsonian patient — clinical and pathophysiological aspects. Can J Neurol Sci. 2003;30(1):19-26.  https://doi.org/10.1017/s0317167100003206
  19. Neves MA, Bouca-Machado R, Guerreiro D, et al. Swimming is compromised in Parkinson’s disease patients. Movement Disorders. 2020;35(2):365-369.  https://doi.org/10.1002/mds.27918
  20. Tosserams A, Nijkrake MJ, Voet Nicoline BM, et al. Why people with Parkinson’s disease experience near-drowning- and how to prevent it? Movement Disorders Clinical Practice. 2020;2:7(5):573-574.  https://doi.org/10.1002/mdc3.12989
  21. Cugusi L, Manca A, Bergamin M, et al. Aquatic exercise improves motor impairments in people with Parkinson’s disease, with similar or greater benefits than land-based exercise: a systematic review. J Physiother. 2019;65(2):65-74.  https://doi.org/10.1016/j.jphys.2019.02.003
  22. Jasinska-Muga B, Heckman MG, Wider C, et al. Loss of ability to work and ability to live independently in Parkinson’s disease. Park Relat Disord. 2012;18(2):130-135.  https://doi.org/10.1016/j.parkreldis.2011.08.022
  23. Smolentseva IG, Amosova NA. Rehabilitation for Parkinson’s Disease: Current Status and Prospects. Byulleten’ Natsional’nogo obshchestva po izucheniyu bolezni Parkinsona i rasstroistv dvizhenii. 2022;2:188-193. (In Russ.). https://doi.org/10.24412/2226-079X-2022-12464
  24. Neves MA, Bouca-Machado R, Guerreiro D, et al. Risk of drowning in people with Parkinson’s disease. Mov disord. 2018;33(9):1507-1508. https://doi.org/10.1002/mds.27473
  25. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;Sep;19(9):1020-1028. https://doi.org/10.1002/mds.20213
  26. Abe K, Fujita M, Yoshikawa H. Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738-750.  https://doi.org/10.1002/mds.10473
  27. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695-699.  https://doi.org/10.1111/j.1532-5415.2005.53221.x
  28. Stern AF. The Hospital Anxiety and Depression Scale. Occupational Medicine. 2014;64(5):393-394.  https://doi.org/10.1093/occmed/kqu024
  29. Nieuwboer A, Rochester L, Herman T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson’s disease and their carers. Gait Posture. 2009;30(4):459-463.  https://doi.org/10.1016/j.gaitpost.2009.07.108
  30. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med. 2003;167(9):12-87.  https://doi.org/10.1164/ajrccm.167.9.950

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.